Population pharmacokinetic modelling of imatinib in healthy subjects receiving a single dose of 400 mg

被引：0
|
作者：
Yi-Han Chien
Gudrun Würthwein
Pablo Zubiaur
Bianca Posocco
María Ángeles Pena
Alberto M. Borobia
Sara Gagno
Francisco Abad-Santos
Georg Hempel
机构：
[1] Westfälische Wilhelms-Universität Münster,Clinical Pharmacology Department
[2] Institut für Pharmazeutische und Medizinische Chemie-Klinische Pharmazie,Experimental and Clinical Pharmacology Unit
[3] Hospital Universitario de la Princesa,Farmacología Clínica
[4] Pharmacology Department,Clinical Pharmacology Department
[5] Faculty of Medicine,undefined
[6] Universidad Autonoma de Madrid,undefined
[7] Instituto de Investigación Sanitaria la Princesa (IIS-Princesa),undefined
[8] Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD),undefined
[9] Centro di Riferimento Oncologico di Aviano (CRO),undefined
[10] IRCCS,undefined
[11] Hospital Universitario Marqués de Valdecilla-Pabellón,undefined
[12] Hospital Universitario La Paz,undefined
[13] Pharmacology Department,undefined
[14] Faculty of Medicine,undefined
[15] Universidad Autonoma de Madrid,undefined
[16] IdiPAZ,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2022年 / 90卷
关键词：
Imatinib; Population pharmacokinetics; NONMEM; Ph + leukemia; Empirical Bayesian estimation; MAP Bayesian estimation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：125 / 136
页数：11
相关论文
共 50 条
  • [1] Population pharmacokinetic modelling of imatinib in healthy subjects receiving a single dose of 400 mg
    Chien, Yi-Han
    Wuerthwein, Gudrun
    Zubiaur, Pablo
    Posocco, Bianca
    Angeles Pena, Maria
    Borobia, Alberto M.
    Gagno, Sara
    Abad-Santos, Francisco
    Hempel, Georg
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2022, 90 (02) : 125 - 136
  • [2] Population Pharmacokinetic Analysis of Hydrocodone Following A Single Dose Administration In Healthy Subjects
    Cheruvu, Narayan P.
    Tata, Prasad
    Devarakonda, Krishna R.
    Ward, Julie
    Pierro, Joseph
    JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 51 (09): : 1360 - 1360
  • [3] Effect of a single oral dose of moxifloxacin (400 mg and 800 mg) on ventricular repolarization in healthy subjects
    Démolis, JL
    Kubitza, D
    Tennezé, L
    Funck-Brentano, C
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2000, 68 (06) : 658 - 666
  • [4] Pharmacokinetic Interaction Between Isavuconazole and a Fixed-Dose Combination of Lopinavir 400 mg/Ritonavir 100 mg in Healthy Subjects
    Yamazaki, Takao
    Desai, Amit
    Han, David
    Kato, Kota
    Kowalski, Donna
    Akhtar, Shahzad
    Lademacher, Christopher
    Kovanda, Laura
    Townsend, Robert
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2017, 6 (01): : 93 - 101
  • [5] Bioequivalence of a single 400-mg dose of imatinib 100-mg oral tablets and a 400-mg tablet in healthy adult Korean volunteers
    Lee, Hae Won
    Seong, Sook Jin
    Park, Sung Min
    Lee, Joomi
    Gwon, Mi-Ri
    Kim, Hyun-Ju
    Lim, Sung Mook
    Lim, Mi-sun
    Kim, Woomi
    Yang, Dong Heon
    Yoon, Young-Ran
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2015, 53 (06) : 480 - 487
  • [6] Pharmacokinetic/pharmacodynamic and safety study of a single dose of evolocumab 140 mg in healthy Chinese subjects
    Lu, Hong
    Yu, Zhigang
    Hsu, Cheng-Pang
    Tomlinson, Brian
    Luk, Andrea On Yan
    Egbuna, Ogo
    Wu, Jihua
    Abosaleem, Bassam
    Rana, Jitesh
    Monsalvo, Maria Laura
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2020, 58 (10) : 557 - 564
  • [7] Population pharmacokinetic modelling of febuxostat in healthy subjects and people with gout
    Kamel, Bishoy
    Abuhelwa, Ahmad Y.
    Foster, David
    Duong, Janna K.
    Graham, Garry G.
    Williams, Kenneth M.
    Pile, Kevin D.
    Day, Richard O.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 88 (12) : 5359 - 5368
  • [8] Population pharmacokinetic modelling and simulation of fremanezumab in healthy subjects and patients with migraine
    Fiedler-Kelly, Jill B.
    Cohen-Barak, Orit
    Morris, Denise N.
    Ludwig, Elizabeth
    Rasamoelisolo, Michele
    Shen, Honglue
    Levi, Micha
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 85 (12) : 2721 - 2733
  • [9] A RANDOMISED, CROSSOVER STUDY TO EVALUATE THE SAFETY AND THE PHARMACOKINETIC PROFILES OF A SINGLE ORAL DOSE (400 MG) OF AMORPHOUS RIFAXIMIN IN COMPARISON WITH A SINGLE ORAL DOSE (400 MG) OF NORMIX® (RIFAXIMIN POLYMORPH-α IN HEALTHY VOLUNTEERS
    Marzo, A.
    Ismaili, S.
    DIGESTIVE AND LIVER DISEASE, 2010, 42 : S191 - S192
  • [10] A pharmacokinetic-pharmacodynamic study of a single dose of febuxostat in healthy subjects
    Kamel, Bishoy
    Graham, Garry G.
    Stocker, Sophie L.
    Liu, Zhixin
    Williams, Kenneth M.
    Carland, Jane E.
    Pile, Kevin D.
    Day, Richard O.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2020, 86 (12) : 2486 - 2496
12345